Cencora, Inc. $COR Shares Sold by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. trimmed its holdings in Cencora, Inc. (NYSE:COR) by 79.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,880 shares of the company’s stock after selling 11,238 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in Cencora were worth $900,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of COR. Norges Bank acquired a new position in shares of Cencora in the 2nd quarter valued at $695,215,000. Mizuho Markets Americas LLC boosted its stake in shares of Cencora by 116.4% during the 3rd quarter. Mizuho Markets Americas LLC now owns 212,800 shares of the company’s stock worth $66,506,000 after acquiring an additional 1,511,906 shares in the last quarter. Artisan Partners Limited Partnership acquired a new stake in shares of Cencora during the 2nd quarter valued at about $411,888,000. Vanguard Group Inc. raised its holdings in Cencora by 5.3% in the 2nd quarter. Vanguard Group Inc. now owns 22,479,041 shares of the company’s stock worth $6,740,340,000 after purchasing an additional 1,125,661 shares during the period. Finally, Viking Global Investors LP boosted its position in Cencora by 95.0% during the second quarter. Viking Global Investors LP now owns 2,081,732 shares of the company’s stock worth $624,207,000 after purchasing an additional 1,013,913 shares in the last quarter. Hedge funds and other institutional investors own 97.52% of the company’s stock.

Insider Activity

In other news, CEO Robert P. Mauch sold 5,096 shares of the firm’s stock in a transaction on Tuesday, January 20th. The stock was sold at an average price of $354.73, for a total transaction of $1,807,704.08. Following the completion of the transaction, the chief executive officer directly owned 66,726 shares in the company, valued at $23,669,713.98. This trade represents a 7.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Silvana Battaglia sold 1,677 shares of the firm’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $345.00, for a total value of $578,565.00. Following the transaction, the executive vice president owned 18,796 shares of the company’s stock, valued at $6,484,620. This trade represents a 8.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 15,220 shares of company stock valued at $5,282,867. Company insiders own 0.38% of the company’s stock.

Cencora Stock Down 0.4%

Shares of NYSE:COR opened at $363.08 on Thursday. Cencora, Inc. has a 52-week low of $248.11 and a 52-week high of $377.54. The company has a quick ratio of 0.51, a current ratio of 0.92 and a debt-to-equity ratio of 3.62. The business has a fifty day moving average of $350.59 and a two-hundred day moving average of $332.78. The stock has a market cap of $70.63 billion, a P/E ratio of 43.64, a PEG ratio of 1.70 and a beta of 0.68.

Cencora (NYSE:COR) last posted its earnings results on Wednesday, February 4th. The company reported $4.08 earnings per share for the quarter, beating the consensus estimate of $4.04 by $0.04. Cencora had a net margin of 0.50% and a return on equity of 176.54%. The company had revenue of $85.93 billion for the quarter, compared to analyst estimates of $86.12 billion. During the same period in the previous year, the business posted $3.73 EPS. Cencora’s revenue was up 5.5% on a year-over-year basis. On average, research analysts expect that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Friday, February 13th. Cencora’s dividend payout ratio (DPR) is 28.85%.

Wall Street Analyst Weigh In

COR has been the subject of several research analyst reports. Jefferies Financial Group raised Cencora from an “underperform” rating to a “buy” rating in a research note on Thursday, January 22nd. Wall Street Zen cut shares of Cencora from a “buy” rating to a “hold” rating in a research note on Friday, November 28th. UBS Group raised their price target on shares of Cencora from $380.00 to $415.00 and gave the company a “buy” rating in a research note on Friday, November 7th. Barclays boosted their price objective on Cencora from $400.00 to $425.00 and gave the stock an “overweight” rating in a research note on Friday, February 13th. Finally, Weiss Ratings upgraded Cencora from a “hold (c+)” rating to a “buy (b)” rating in a research report on Thursday, February 5th. Eleven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $399.00.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.